Professor Bernard Do

Professor Bernard Do, a hospital pharmacist and full professor at Université Paris-Saclay, has been Head of the Department of Clinical Pharmacy at Gustave Roussy since 2024. He leads clinical pharmacy operations and the development of investigational drugs used in institutional clinical trials.

Villejuif, 19 May 2025

The presence of tumour DNA in the blood could shape follow-up care for cancer patients

Gustave Roussy announces the launch of UMBRELLA, a ground-breaking phase III clinical trial that could profoundly transform how cancer patients are monitored after curative treatment. The objective is to personalise post-treatment follow-up based on the presence or absence of minimal residual disease (MRD), which is detected in the blood via circulating tumour DNA analysis.

Deuxième avis médical

Une demande gratuite, simple et rapide, depuis chez vous

Professor Christophe Massard

Dr Maximiliano Gelli

25 april 2025

Age-related genetic changes in the blood associated with poor cancer prognosis

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to ageing, can be found in cancerous tumours, and this is associated with worse outcomes for patients.

Les Centres Interception en France

Depuis 2024, le programme Interception s’étend de façon nationale afin de proposer un même parcours de prévention personnalisée à toute personne à risque augmenté de cancer en France.